• Jazz' small cell lung cancer therapy wins US green light pharmatimes
    June 17, 2020
    Jazz Pharmaceuticals and PharmaMar have announced US approval of Zepzelca (lurbinectedin) for the treatment of adults with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy.
PharmaSources Customer Service